Radiotherapy for Keloids

Part of paid clinical trials in The Bronx, New York.

Sponsor
Montefiore Medical Center
Study ID
NCT04722263
Status
Recruiting
Apply to this trial

Conditions

  • Keloid

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Radiotherapy — RADIATION
    25 Gy in 5 fractions

Study Details

The purpose of this pilot study is to evaluate the safety and efficacy of radiation therapy (RT) in the treatment of unresected keloids.

Key Dates

Start date
Dec 1, 2020
Status verified
Jan 2026
Primary completion
Jun 30, 2026
Completion
Jun 30, 2026

Study Design

Enrollment
15 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Radiotherapy for patients with nonresectable keloids
    Patients will be seen by a treating radiation oncologist and treatment with the assigned dose schedule will be planned using either EBRT with electrons or high dose-rate radiotherapy (HDR) brachytherapy as deemed appropriate by the treating radiation oncologist. The treatment dose of 25 Gy in 5 fractions will be prescribed to the 90% isodose line.

Primary Outcome Measure

Treatment-related toxicities [ Time Frame: Up to 1 year (+/- 1 month) post radiotherapy ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Montefiore Medical CenterThe BronxNew York10467
Keyur Mehta, MD
[email protected]
718-920-5636

Find similar trials in The Bronx, NY

By research site
Montefiore Medical Center· The Bronx, NY

Related Studies